TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive In Brief: Howard Skipper Retires; Oglesby To Head SRI; John Montgomery Named Kettering-Meyer Director December 19, 1980
TCL Archive Public Health Service: Scientific Papers Become “Deliverables” In Own RFP October 3, 1997
TCL Archive In Brief: Congress Sets NCI Rescission At $10.785 Million; Centers to Be Funded According To Priority Scores June 12, 1981
